Connect AccountAll persons or entities that purchased or otherwise acquired Immunomedics common stock during the period between February 9, 2018 and January 17, 2019, inclusive.
Final Approval
February 08, 2018 - April 17, 2019
June 15, 2019
May 25, 2023
JND Legal Administration
Immunomedics Securities SettlementClaims Administratorc/o JND Legal AdministrationP.O. Box 91456Seattle, WA 98111
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.